# Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer

> **NCT03686683** · PHASE3 · COMPLETED · sponsor: **Dendreon** · enrollment: 532 (actual)

## Conditions studied

- Adenocarcinoma of the Prostate

## Interventions

- **BIOLOGICAL:** sipuleucel-T

## Key facts

- **NCT ID:** NCT03686683
- **Lead sponsor:** Dendreon
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-18
- **Primary completion:** 2023-03-10
- **Final completion:** 2023-03-10
- **Target enrollment:** 532 (ACTUAL)
- **Last updated:** 2024-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03686683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03686683, "Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03686683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*